Centre of Excellence for Nutrition, North-West University, Potchefstroom, South Africa.
Department of Physics, Wake Forest University, Winston-Salem, North Carolina, United States.
Thromb Haemost. 2020 Jan;120(1):44-54. doi: 10.1055/s-0039-1698460. Epub 2019 Nov 21.
Turbidimetry is used to characterize fibrin clot properties. In purified systems, maximum absorbance (MA) directly relates to fibrin fiber cross-sectional area. However, in plasma samples there are discrepancies in the relationships between MA and fibrinogen concentration, fiber diameter, other clot properties, and cardiovascular disease outcomes, which complicate data interpretation. This study aims to advance understanding of MA of plasma clots through testing how well it relates to fundamental dependence on fibrinogen concentration and fiber diameter as predicted by light scattering theory, other clot properties and lifestyle, and biochemical variables. Plasma samples from 30 apparently healthy individuals with a fibrinogen concentration from 2.4 to 6.4 g/L were included. We performed turbidimetry, permeability, scanning electron microscopy, and rheometry on formed plasma clots. MA correlated more strongly with fibrinogen concentration ( = 0.65; < 0.001) than with fiber diameter ( = 0.47; = 0.01), which combined explained only 46% of the MA variance. Of additional variables measured, only low-density lipoprotein cholesterol correlated with MA ( = 0.46; = 0.01) and clot lysis ( = 0.62; < 0.0001) but not with fiber diameter or fibrinogen concentration. MA correlated with clot lysis time ( = 0.59; = 0.001), storage modulus ( = 0.61; = 0.001), and loss modulus ( = 0.59; = 0.001), and negatively with clot permeability ( = -0.60; = 0.001) also after adjustment for fibrinogen concentration and fiber diameter. Increased MA is indicative of a prothrombotic clot phenotype irrespective of fibrinogen concentration. MA is more indicative of overall clot density than of fiber diameter. Other plasma components can alter internal fiber density without altering fiber diameter and should be considered when interpreting MA of plasma samples.
比浊法用于描述纤维蛋白凝块特性。在纯体系中,最大吸光度(MA)与纤维横截面面积直接相关。然而,在血浆样本中,MA 与纤维蛋白原浓度、纤维直径、其他凝块特性以及心血管疾病结局之间的关系存在差异,这使得数据解释变得复杂。本研究旨在通过测试 MA 与纤维蛋白原浓度和纤维直径之间的基本依赖性的相关性来进一步了解血浆凝块的 MA,这些依赖性是由光散射理论预测的,还包括其他凝块特性、生活方式和生化变量。纳入了 30 名纤维蛋白原浓度为 2.4 至 6.4g/L 的健康个体的血浆样本。我们对形成的血浆凝块进行了比浊法、渗透性、扫描电子显微镜和流变学检测。MA 与纤维蛋白原浓度的相关性( = 0.65; < 0.001)强于与纤维直径的相关性( = 0.47; = 0.01),这两个因素共同仅能解释 MA 变异的 46%。在测量的其他变量中,只有低密度脂蛋白胆固醇与 MA( = 0.46; = 0.01)和凝块溶解( = 0.62; < 0.0001)相关,而与纤维直径或纤维蛋白原浓度无关。MA 与凝块溶解时间( = 0.59; = 0.001)、储能模量( = 0.61; = 0.001)和损耗模量( = 0.59; = 0.001)相关,与凝块渗透性( = -0.60; = 0.001)相关,在调整纤维蛋白原浓度和纤维直径后也是如此。增加的 MA 表明存在血栓形成的凝块表型,而与纤维蛋白原浓度无关。MA 更能反映整体凝块密度,而不是纤维直径。其他血浆成分可以在不改变纤维直径的情况下改变内部纤维密度,在解释血浆样本的 MA 时应予以考虑。